secwatch / observer
8-K filed December 8, 2025, 6:59 PM ET ticker GRML CIK 0001907223
other material confidence high sentiment neutral materiality 0.70

Klotho Neurosciences raises ~$15M via sale of Series C convertible preferred stock to Sigma9 Capital

Greenland Mines Ltd

Key facts

Extracted from this filing and checked against the source text.

Equity Issuances SEC 8-K Item 3.02/3.03 confidence 0.9

Greenland Mines Ltd issued 3,400 shares of preferred stock to Sigma9 Capital, Ltd. for $4,400.00 per share.

Security
preferred stock
Shares
3,400 shares
Purchaser
Sigma9 Capital, Ltd.
Consideration
$4,400.00 per share
Exact text from the filing
On December 2, 2025, the Company entered into a Securities Purchase Agreement (the “Agreement”) with Sigma9 Capital, Ltd., pursuant to which the Company agreed to issue and sell to the investor 3,400 shares of a new class of the Company’s preferred stock to be designated as Series C Preferred Stock, at a price of $4,400.00 per share.
View on SEC.gov
Material Agreements SEC 8-K Item 1.01/1.02 confidence 1.0

Greenland Mines Ltd entered into Securities Purchase Agreement with Sigma9 Capital, Ltd. valued at $4,400.00 per share (effective 2025-12-02).

Action
entry
Agreement
equity purchase
Counterparty
Sigma9 Capital, Ltd.
Value
$4,400.00 per share
Effective
2025-12-02
Exact text from the filing
On December 2, 2025, Klotho Neurosciences, Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Agreement”) with an investor, Sigma9 Capital, Ltd., pursuant to which the Company agreed to issue and sell to the investor 3,400 shares of a new class of the Company’s preferred stock to be designated as Series C Preferred Stock, at a price of $4,400.00 per share.
View on SEC.gov

Browse all equity issuances →

Greenland Mines Ltd filing history →

Source: SEC EDGAR
accession 0001213900-25-119257
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.